common.study.topics.clinical

Expanded Indications in Adult Cochlear Implant Population

common.study.values.description

Expanded Indications in the Adult Cochlear Implant Population

The purpose of this investigation is to expand FDA-approved labeling for MED-EL cochlear implants to include adults who have moderate to profound sensorineural hearing loss and obtain limited benefit from appropriately fit hearing aids.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Device - MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System

Subjects will be implanted with the MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System with +FLEX28 or +FLEXSOFT electrode arrays. Subjects will be fit with the SONNETEAS (ear-level) and/or RONDO (single-unit) external audio processors.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Expanded Indications in the Adult Cochlear Implant Population

common.study.values.clinical-trial-id

NCT03236909

participant.views.study.view.id

1aMl3e